Although advertisements promote the drug as safe and effective, with few long-term side effects, Latham and other former users are now pursuing Ozempic lawsuits and Wegovy lawsuits against Novo Nordisk, each raising similar allegations that the widespread use of the drugs has made it clear that the drug label fails to adequately warn about the risk of severe and long-lasting gastroparesis side effects
GLP-1 receptors are widely distributed in the central nervous system, especially in regions related to appetite regulation, memory, and learning, including the hippocampus, hypothalamus, and brainstem
DSIP: Aids in improving sleep quality by inducing delta sleep
Plan sponsor implications Alberta Blue Cross frames the 2026 pipeline report as a tool to help plan sponsors anticipate new cost drivers and high-impact therapies, supporting what it calls informed decision making on proactive benefit management strategies to balance patient access with sustainable plan design [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php]